Cowen Reiterates Outperform Rating on Aptinyx (APTX), Sees "Better Rationale" for 2925 in Fibromyalgia Apr 7, 2022 04:44PM
Aptinyx to Participate in the 42nd Annual Cowen Health Care Conference Mar 1, 2022 07:47AM
Aptinyx Highlights Key Goals and Anticipated Development Milestones for 2022 Jan 6, 2022 07:37AM
Aptinyx to Participate in Cowen Psychedelics & Novel Mechanisms in Neuropsychiatry Summit Jul 6, 2021 07:57AM
Aptinyx to Participate in Upcoming Investor Conferences Feb 22, 2021 08:30AM


Feb 19, 2020 08:37AM Aptinyx to Present at Upcoming Investor Conferences
Feb 19, 2020 08:37AM Aptinyx to Present at Upcoming Investor Conferences
Jan 14, 2020 04:01PM Aptinyx Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters’ Option
Jan 14, 2020 04:01PM Aptinyx Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters’ Option
Jan 10, 2020 09:01AM Aptinyx (APTX) Prices 10.17M Share Common Stock Offering at $3/shh
Jan 10, 2020 09:00AM Aptinyx Announces Pricing of Public Offering of Common Stock
Jan 10, 2020 09:00AM Aptinyx Announces Pricing of Public Offering of Common Stock
Jan 9, 2020 04:08PM Aptinyx (APTX) Plans Public Offering of Common Stock
Jan 9, 2020 04:08PM Aptinyx Announces Proposed Public Offering of Common Stock
Jan 9, 2020 04:08PM Aptinyx Announces Proposed Public Offering of Common Stock
Mar 6, 2019 08:00AM Aptinyx to Present at Cowen and Company 39th Annual Health Care Conference
Mar 6, 2019 08:00AM Aptinyx to Present at Cowen and Company 39th Annual Health Care Conference
Jul 16, 2018 05:35AM Cowen Starts Aptinyx (APTX) at Outperform
Jun 25, 2018 05:18PM Aptinyx Announces Closing of Initial Public Offering and Full Exercise of Underwriters' Option to Purchase Additional Shares
Jun 21, 2018 10:44AM Aptinyx (APTX) IPO Opens 9% Higher
Jun 21, 2018 06:31AM Aptinyx Inc. (APTX) Prices 6.4M Share IPO at $16/Sh
Jun 20, 2018 08:41PM Aptinyx Announces Pricing of Initial Public Offering